We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Scientists Unwind More Mysteries of the Cellular Clock

By LabMedica International staff writers
Posted on 08 Dec 2014
Print article
Image: Color coding of genes activated in the liver (yellow) as waves of their activation relative to the time of day. Zeitbeger times (ZT):  ZT0= 7 am, ZT3=10 am, ZT6=1 pm, etc. (Photo courtesy of Dr. Bin Fang, Perelman School of Medicine, University of Pennsylvania).
Image: Color coding of genes activated in the liver (yellow) as waves of their activation relative to the time of day. Zeitbeger times (ZT): ZT0= 7 am, ZT3=10 am, ZT6=1 pm, etc. (Photo courtesy of Dr. Bin Fang, Perelman School of Medicine, University of Pennsylvania).
A new study surveying circadian gene expression provides a new understanding of how one clock leads to at least 8 different subclocks, and may suggest a new venue for drug treatment of clock-based metabolic disorders.

Human existence is basically circadian in that most people wake in the morning, sleep in the evening, and eat in between. Body temperature, metabolism, and hormone levels all fluctuate throughout the day and disruption of those cycles can lead to disorders and diseases. The wheels and springs of the molecular clock underlying these circadian rhythms include transcription factors (TFs) that control oscillation of expression of circadian genes.

Not all circadian cycles peak at the same time – some peak in the morning, others in the evening, etc. The question is how does a single clock keep time in multiple phases at once? 

New findings come from the team of Mitchell Lazar, MD, PhD, and professor at the University of Pennsylvania’s Perelman School of Medicine (Philadelphia, PA, USA) in a report of a genome-wide survey of circadian protein-coding genes and gene-expression enhancers, parts of the “dark matter” of the genome in that they don’t encode for proteins. The team took advantage of new tools based on high-density DNA sequencing to measure the activity of enhancers throughout the day in the livers of mice. They found that many enhancers, like circadian genes themselves, have a daily oscillation that is in phase with nearby genes – both the enhancer and gene activity peak at the same time each day. The activities of the enhancers themselves are, in turn, governed by distinct TFs.

Grouping the enhancers into 8, 3-hour phases based on when they peak, the team asked which TFs are capable of binding to the enhancers in each set. Remarkably, the team found that enhancers that are in the same phase tend to be bound by the same TFs. For instance, one circadian component, CLOCK, binds enhancers that are most active during one particular 3-hour period. Another protein, Rev-erba, binds 12 hours later. Loss of any one of the TFs dysregulates a subset of oscillating genes while leaving genes tuned to other circadian phases unaffected.

“Different transcription factors control different phases,” said Lazar, “That explains how one clock leads to at least 8 different subclocks.”

Also important is that genes that oscillate with the same phase tend to have related functions, which are distinct from the pathways controlled at other times. Genes involved in insulin signaling peak at a different time than genes that control sugar metabolism, for instance.

Lazar suggests it might be possible to tweak pharmaceutical regimens to make them more efficient by delivering drugs only when the pathways they impact are actually active – a strategy that could minimize unintended side effects. Toward “a proof-of-concept for a new principle of drug treatment for metabolic disorders,” he said, “this is a real step in that direction.”

The study, by Fang B, Everett L, Jager J, et al., was published in the journal Cell, online ahead of print November 20, 2014.

Related Links:

Perelman School of Medicine at the University of Pennsylvania
University of Pennsylvania Health System 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.